<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d106">
    <sentence id="DDI-DrugBank.d106.s0" text="A 30 to 45% increase in AUC and Cmax of nisoldipine was observed with concomitant administration of cimetidine 400 mg twice daily.">
        <entity charOffset="40-50" id="DDI-DrugBank.d106.s0.e0" text="nisoldipine" type="drug"/>
        <entity charOffset="100-116" id="DDI-DrugBank.d106.s0.e1" text="cimetidine 400 mg" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s0.e0" e2="DDI-DrugBank.d106.s0.e1" id="DDI-DrugBank.d106.s0.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d106.s1" text="Ranitidine 150 mg twice daily did not interact significantly with nisoldipine (AUC was decreased by 15-20 %).">
        <entity charOffset="0-9" id="DDI-DrugBank.d106.s1.e0" text="Ranitidine" type="drug"/>
        <entity charOffset="66-76" id="DDI-DrugBank.d106.s1.e1" text="nisoldipine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s1.e0" e2="DDI-DrugBank.d106.s1.e1" id="DDI-DrugBank.d106.s1.p0"/>
    <negationtags>Ranitidine 150 mg twice daily did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; interact significantly with nisoldipine (AUC was decreased by 15-20 %). &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s2" text="No pharmacodynamic effects of either histamine H2 receptor antagonist were observed.">
        <entity charOffset="37-68" id="DDI-DrugBank.d106.s2.e0" text="histamine H2 receptor antagonist" type="group"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; pharmacodynamic effects of either histamine H2 receptor antagonist were observed. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s3" text="Coadministration of phenytoin with 40 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.">
        <entity charOffset="20-28" id="DDI-DrugBank.d106.s3.e0" text="phenytoin" type="drug"/>
        <entity charOffset="41-45" id="DDI-DrugBank.d106.s3.e1" text="SULAR" type="brand"/>
        <entity charOffset="89-99" id="DDI-DrugBank.d106.s3.e2" text="nisoldipine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s3.e0" e2="DDI-DrugBank.d106.s3.e1" id="DDI-DrugBank.d106.s3.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s3.e0" e2="DDI-DrugBank.d106.s3.e2" id="DDI-DrugBank.d106.s3.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s3.e1" e2="DDI-DrugBank.d106.s3.e2" id="DDI-DrugBank.d106.s3.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d106.s4" text="Coadministration of SULAR with phenytoin or any known CYP3A4 inducer should be avoided and alternative antihypertensive therapy should be considered.">
        <entity charOffset="20-24" id="DDI-DrugBank.d106.s4.e0" text="SULAR" type="brand"/>
        <entity charOffset="31-39" id="DDI-DrugBank.d106.s4.e1" text="phenytoin" type="drug"/>
        <entity charOffset="103-118" id="DDI-DrugBank.d106.s4.e2" text="antihypertensive" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s4.e0" e2="DDI-DrugBank.d106.s4.e1" id="DDI-DrugBank.d106.s4.p0" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s4.e0" e2="DDI-DrugBank.d106.s4.e2" id="DDI-DrugBank.d106.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s4.e1" e2="DDI-DrugBank.d106.s4.e2" id="DDI-DrugBank.d106.s4.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d106.s5" text="Pharmacokinetic interactions between nisoldipine and beta-blockers (atenolol, propranolol) were variable and not significant.">
        <entity charOffset="37-47" id="DDI-DrugBank.d106.s5.e0" text="nisoldipine" type="drug"/>
        <entity charOffset="53-65" id="DDI-DrugBank.d106.s5.e1" text="beta-blockers" type="group"/>
        <entity charOffset="68-75" id="DDI-DrugBank.d106.s5.e2" text="atenolol" type="drug"/>
        <entity charOffset="78-88" id="DDI-DrugBank.d106.s5.e3" text="propranolol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e0" e2="DDI-DrugBank.d106.s5.e1" id="DDI-DrugBank.d106.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e0" e2="DDI-DrugBank.d106.s5.e2" id="DDI-DrugBank.d106.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e0" e2="DDI-DrugBank.d106.s5.e3" id="DDI-DrugBank.d106.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e1" e2="DDI-DrugBank.d106.s5.e2" id="DDI-DrugBank.d106.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e1" e2="DDI-DrugBank.d106.s5.e3" id="DDI-DrugBank.d106.s5.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s5.e2" e2="DDI-DrugBank.d106.s5.e3" id="DDI-DrugBank.d106.s5.p5"/>
    <negationtags>Pharmacokinetic interactions between nisoldipine and beta-blockers (atenolol, propranolol) were variable and &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; significant. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s6" text="Propranolol attenuated the heart rate increase following administration of immediate release nisoldipine.">
        <entity charOffset="0-10" id="DDI-DrugBank.d106.s6.e0" text="Propranolol" type="drug"/>
        <entity charOffset="93-103" id="DDI-DrugBank.d106.s6.e1" text="nisoldipine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s6.e0" e2="DDI-DrugBank.d106.s6.e1" id="DDI-DrugBank.d106.s6.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d106.s7" text="The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy.">
        <entity charOffset="29-33" id="DDI-DrugBank.d106.s7.e0" text="SULAR" type="brand"/>
        <entity charOffset="71-78" id="DDI-DrugBank.d106.s7.e1" text="atenolol" type="drug"/>
        <entity charOffset="109-124" id="DDI-DrugBank.d106.s7.e2" text="antihypertensive" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s7.e0" e2="DDI-DrugBank.d106.s7.e1" id="DDI-DrugBank.d106.s7.p0" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s7.e0" e2="DDI-DrugBank.d106.s7.e2" id="DDI-DrugBank.d106.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s7.e1" e2="DDI-DrugBank.d106.s7.e2" id="DDI-DrugBank.d106.s7.p2"/>
    <negationtags>The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; other antihypertensive therapy. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s8" text="Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but not the peak concentration.">
        <entity charOffset="0-8" id="DDI-DrugBank.d106.s8.e0" text="Quinidine" type="drug"/>
        <entity charOffset="63-73" id="DDI-DrugBank.d106.s8.e1" text="nisoldipine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s8.e0" e2="DDI-DrugBank.d106.s8.e1" id="DDI-DrugBank.d106.s8.p0" type="mechanism"/>
    <negationtags>Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; the peak concentration. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s9" text="The immediate release, but not the coat-core formulation of nisoldipine increased plasma quinidine concentrations by about 20%.">
        <entity charOffset="60-70" id="DDI-DrugBank.d106.s9.e0" text="nisoldipine" type="drug"/>
        <entity charOffset="89-97" id="DDI-DrugBank.d106.s9.e1" text="quinidine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d106.s9.e0" e2="DDI-DrugBank.d106.s9.e1" id="DDI-DrugBank.d106.s9.p0" type="mechanism"/>
    <negationtags>The immediate release, but &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; the coat-core formulation of nisoldipine increased plasma quinidine concentrations by about 20%. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s10" text="This interaction was not accompanied by ECG changes and its clinical significance is not known."><negationtags>This interaction was &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; accompanied by ECG changes and its clinical significance is not known. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d106.s11" text="No significant interactions were found between nisoldipine and warfarin or digoxin.">
        <entity charOffset="47-57" id="DDI-DrugBank.d106.s11.e0" text="nisoldipine" type="drug"/>
        <entity charOffset="63-70" id="DDI-DrugBank.d106.s11.e1" text="warfarin" type="drug"/>
        <entity charOffset="75-81" id="DDI-DrugBank.d106.s11.e2" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s11.e0" e2="DDI-DrugBank.d106.s11.e1" id="DDI-DrugBank.d106.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s11.e0" e2="DDI-DrugBank.d106.s11.e2" id="DDI-DrugBank.d106.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d106.s11.e1" e2="DDI-DrugBank.d106.s11.e2" id="DDI-DrugBank.d106.s11.p2"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No significant &lt;/cue&gt; interactions were found between nisoldipine and warfarin or digoxin. &lt;/scope&gt;</negationtags></sentence>
</document>